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Neural tube defects are common and serious human congenital anomalies. These malformations have a multifactorial
etiology and can be reproduced in mouse models by mutations of numerous individual genes and by perturbation of multiple
environmental factors. The identification of specific genetic interactions affecting neural tube closure will facilitate our
understanding of molecular pathways regulating normal neural development and will enhance our ability to predict and
modify the incidence of spina bifida and other neural tube defects. Here, we report a genetic interaction between Nf1,
encoding the intracellular signal transduction protein neurofibromin, and Pax3, a transcription factor gene mutated in the
Splotch mouse. Both Pax3 and Nf1 are important for the development of neural crest-derived structures and the central
nervous system. Splotch is an established model of folate-sensitive neural tube defects, and homozygous mutant embryos
evelop spina bifida and sometimes exencephaly. Neural development is grossly normal in heterozygotes and neural tube
efects are not seen. In contrast, we found a low incidence of neural tube defects in heterozygous Splotch mice that also
arbored a mutation in one Nf1 allele. All compound homozygotes had severe neural tube defects and died earlier in
mbryogenesis than either Nf12/2 or Sp2/2 embryos. We also report occasional exencephaly in Nf12/2 mice and identify more
ubtle CNS abnormalities in normal-appearing Nf12/2 embryos. Though other genetic loci and environmental factors affect
the incidence of neural tube defects in Splotch mice, these results establish Nf1 as the first known gene to act as a modifier
f neural tube defects in Splotch. © 1999 Academic Press
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Development of the embryonic CNS, from the neural
plate to the closed neural tube, is a complex event requiring
the orchestration of many genes and cellular processes.
Disruptions or alterations in this process result in aberrant
neural tube closure and neural tube defects (NTDs). NTDs
are among the most common and devastating congenital
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80alformations that affect approximately 1–9 in 1000 births
orldwide (Edmonds and James, 1990; Lemire, 1988; Na-
ano, 1973; Richards et al., 1972). They are second only to
ongenital heart defects in causing mortality among new-
orns. NTDs most frequently occur at the two ends of the
eural tube. Rostral NTDs result in anencephaly (exen-
ephaly in mice (Laurence et al., 1983; Neumann et al.,
994)) and caudal defects in spina bifida.
The mouse has been a useful model for the study of
TDs. Analyses of numerous transgenic and targeted mu-
ant mice have implicated many new genes in the patho-
enesis of neural tube closure defects. More than 40 genes,
hen mutated, can cause NTDs in mice (reviewed by
arris and Juriloff, 1997). Environmental factors also im-
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81Neural Tube Defects in Nf1/Splotch Micepact significantly upon neural tube closure in both mice
and men, as exemplified by the dramatic impact of mater-
nal folic acid treatment for the prevention of spina bifida
(reviewed by Butterworth and Bendich, 1996). These factors
together underscore that neurulation is dependent on com-
plex interactions between genes and the environment.
However, little is known about the interactions between
genetic and environmental factors or about genetic hierar-
chies regulating neural tube closure. Notable progress in
this regard has emerged from the study of the Splotch
mouse, which serves as an excellent model for both spina
bifida and exencephaly (Auerbach, 1954).
All known alleles of Splotch are caused by mutations or
deletions of the Pax3 gene. Pax3 encodes a nuclear tran-
cription factor expressed before neural tube closure in the
orsal prosencephalon and extending posteriorly. Expres-
ion continues in the dorsal neural tube throughout the
eriod of neural tube closure, and then dissipates. Pax3 is
lso expressed in neural crest, dorsal root and sympathetic
anglia, and the somite (Goulding et al., 1991). Heterozy-
ous Splotch mice have a pigmentation defect manifest as a
white belly spot but are otherwise normal. Homozygous
embryos die during midgestation and nearly always display
spina bifida in the lumbosacral region, exencephaly, or both
(Auerbach, 1954). In humans, PAX3 mutations cause Waar-
denburg syndrome (Tassabehji et al., 1992). Occasional
NTDs have been reported in heterozygous patients (Chat-
kupt et al., 1993; Nye et al., 1998), and severe NTDs have
been observed in a homozygous human infant (Ayme and
Philip, 1995). Both mice and human data are consistent
with a gene-dosage effect related to neural tube closure.
Strikingly, folic acid therapy has recently been shown to
reduce the incidence of NTDs in Splotch mice (Fleming and
Copp, 1998), further supporting the use of Splotch as a
model for human NTDs. Nevertheless, molecular pathways
regulated by Pax3 during neurulation remain largely un-
known. A genetic interaction between Splotch and curly
tail in which compound mutant embryos have an increased
incidence of NTDs has been described (Estibeiro et al.,
1993). Unfortunately, the gene on mouse chromosome 4
responsible for the curly tail phenotype has not yet been
identified (Neumann et al., 1994).
NF1 is a tumor suppressor gene that is mutated in von
Recklinghausen Neurofibromatosis, one of the most com-
mon inherited neurological disorders in humans. Neurofi-
bromatosis is a variable disorder that includes a range of
signs and symptoms including multiple neurofibromas,
cafe-au-lait spots, and the development of secondary malig-
nancies (reviewed by Gutmann et al., 1997). The function
and the molecular pathway(s) regulated by the NF1 gene
product, neurofibromin, are only partially understood. Neu-
rofibromin is a large protein (2818 aa) that contains a
GTPase-activating protein (GAP)-related domain (Ballester
et al., 1990; Martin et al., 1990; Xu et al., 1990). Neurofi-
bromin can enhance the intrinsic GTPase activity of p21-
ras bound to GTP and consequently down-regulate ras
signaling (Bollag et al., 1996; Hattori et al., 1992). Nf1 is
g
m
Copyright © 1999 by Academic Press. All rightexpressed in multiple embryonic tissues, including rela-
tively high levels in the developing CNS prior to neural
tube closure (Daston and Ratner, 1992; Gutmann et al.,
1995; Huynh et al., 1994). In the adult, expression is
restricted to neural tissue (Nordlund et al., 1993, 1995). Nf1
has been suggested to regulate neuronal differentiation, and
mutations have been correlated with the progression of
neuroectodermal tumors (Steck and Saya, 1991). In mice,
neurofibromin deficiency affects neuronal growth behavior
by altering the response to neurotrophin growth factors
(Vogel et al., 1995). Humans and mice heterozygous mutant
for Nf1 have learning disabilities (Silva et al., 1997; Taka-
hashi et al., 1994). NTDs have not been reported at in-
creased frequency in human NF1 patients and were not
initially described after inactivation of the Nf1 gene in mice
(Brannan et al., 1994; Jacks et al., 1994). However, an
increased incidence of NTDs has been reported in mice
lacking both Nf1 and p53 (Vogel and Parada, 1998) and in
mice lacking both Nf1 and p120-rasGAP (Henkemeyer et
l., 1995).
Here, we report the identification of Nf1 as a modifier of
Pax3 in the development of NTDs in mice. We set out to
examine a possible genetic interaction between Nf1 and
ax3 because of the striking overlap in developing tissues
ffected by mutations in these genes. For instance, inacti-
ation of either gene results in abnormal morphogenesis of
he cardiac outflow tract that is populated by neural crest
ells (Brannan et al., 1994; Franz, 1989; Jacks et al., 1994).
Both genes play roles in peripheral ganglia formation and in
melanocyte and Schwann cell function (Auerbach, 1954;
Brannan et al., 1994; Jacks et al., 1994; Kioussi et al., 1995).
In addition, a potential binding site for Pax3 has been
identified in the Nf1 gene, suggesting that Pax3 might
directly regulate Nf1 expression (Epstein et al., 1995). We
postulated that if Nf1 expression was dependent on Pax3,
double homozygous deficient embryos would have a phe-
notype identical to that of Splotch embryos. Instead, we
found that Nf1 deficiency augmented the Splotch pheno-
type.
In this study, we report that a low percentage of Nf1
homozygous embryos display exencephaly. In addition,
some mutant embryos without exencephaly display abnor-
mal CNS development and enlarged dorsal root ganglia.
Compound homozygotes of Nf1 and Pax3 display early
lethality and severe NTDs in all cases identified. A low
incidence of NTDs was also identified in Nf1, Pax3 com-
pound heterozygotes, strongly supporting the conclusion
that a genetic interaction between Nf1 and Pax3 contrib-
utes to neural tube closure.
MATERIALS AND METHODS
Mice Breeding and Genotyping
Nf11/2 heterozygous mice generated by gene targeting were
enerously provided by Dr. Tyler Jacks (Jacks et al., 1994) and
aintained on a 129/sv background. Splotch (Sp1/2) mice on
s of reproduction in any form reserved.
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82 Lakkis et al.C57Bl/6 background were obtained from The Jackson Laboratories.
Nf1 and Sp heterozygotes were crossed to obtain compound het-
rozygous (Nf11/2, Sp1/2) males and females which were inter-
rossed. Noon of the day of the vaginal plug was considered day 0.5
f gestation (E0.5). Mice were housed at the animal care facility of
he Children Hospital of Pennsylvania with a 12/12-h light–dark
ycle. The genotypes of the adult mice and embryos with respect to
f1 and Sp alleles were identified by PCR of genomic DNA
xtracted from tail biopsies and extraembryonic membranes as
reviously described (Jacks et al., 1994; Tajbakhsh et al., 1997). The
ender of the embryos was determined using PCR with primers for
he male-specific Zfy gene (Page et al., 1987).
Histology
Isolated embryos were fixed in 4% paraformaldehyde in PBS at
4°C overnight followed by dehydration in a series of increasing
concentrations of EtOH, clearing in xylenes, and paraffin embed-
ding in Paraplast. Serial sections (8 mM) were mounted on Super-
rost slides (Fisher) and processed for routine Giemsa or hematoxy-
in and eosin staining.
In Situ Hybridization
35S-labeled probes for Nf1, Pax-3, Pax-6, neuregulin, and ErbB3
were synthesized by run-off transcription of linearized plasmids.
Prehybridization, hybridization, and posthybridization were car-
ried out as described (Lutz et al., 1994). Slides were then dipped in
Kodak NTB2 emulsion and exposed for 10–14 days at 4°C, after
which they were developed and fixed in Kodak Dektol developer
and fixer, counterstained with Hoechst 33258 (Sigma) for 2 min,
washed, dried, and mounted in Canada Balsam.
Semiquantitative RT-PCR
RNA was prepared from the head region of five wild-type and
five Splotch E10.5 embryos and pooled according to genotype. One
undred nanograms of mRNA from wild-type and Splotch embryos
was reverse transcribed using SuperScript II Reverse Transcriptase
(Life Technologies) in a 20-ml reaction according to the manufac-
turer’s protocol. Increasing quantities of reaction products (0.25,
0.5, 1.0, and 2 ml) were subjected to PCR using Nf1-specific and
b-actin-specific (control) primers in the same PCR tube. The
products of the RT-PCR were compared on 2% agarose gels. The
TABLE 1
Exencephaly in Some Female Nf1 Homozygous Embryos
E10.5
(No. exencephaly, female) (No. exenc
f11/1 31 16
f11/2 73 43
f12/2 19 (3E,F)a 13
Total 123 72
Note. Genotypes of embryos examined from Nf11/2 crosses at E10
in Nf12/2 embryos.
a The number of embryos with exencephaly (E) is given in parennumber of PCR cycles was adjusted in preliminary experiments
such that the observed band intensities were in the linear range.
Copyright © 1999 by Academic Press. All rightStatistics
Standard x2 analysis was performed comparing observed (O) to
expected (E) frequencies and included the Yate’s correction (½) for
analyses with 1 degree of freedom:
x 2 5 O~uO 2 Eu 2 12! 2E .
RESULTS
Exencephaly in Nf1-Deficient Embryos
Embryos from the crosses of 129/sv, Nf1/1 heterozygous
parents were examined at E13.5 (79 embryos), E12.5 (72
embryos), and E10.5 (123 embryos). The results are summa-
rized in Table 1. At E13.5, 2 embryos of 16 homozygous
mutants displayed exencephaly (both females). At E12.5, 1
of 13 homozygous mutants (also female) displayed exen-
cephaly. At E10.5, 3 embryos (all female) with exencephaly
were observed among 19 homozygous mutants. Thus, 6 of
48 (12.5%) homozygotes had gross defects of cranial neural
tube closure. No spina bifida was observed in any Nf1-null
utant and no neural tube abnormality was observed in
ild-type embryos or in Nf1 heterozygotes. The incidence
of exencephaly was reduced when Nf1 mutants were
crossed onto mixed genetic backgrounds (1 of 13 Nf12/2
embryos crossed onto a C57Bl/6 background had exen-
cephaly). Overall, we observed fewer Nf12/2 embryos than
expected at E10.5–13.5, suggesting partial embryonic lethal-
ity at earlier time points (Table 1).
Increased Incidence of Neural Tube Defects
in Nf1/Splotch Mice
Nf11/2 and Sp1/2 mice were crossed to obtain compound
heterozygote (Nf11/2, Sp1/2) offspring. Compound heterozy-
gotes were then crossed and litters were examined at
designated stages of embryogenesis. Of 73 embryos exam-
ined at E13.5, no double homozygous mutants were ob-
tained (Table 2), suggesting earlier lethality of embryos
ly, female)
E13.5
(No. exencephaly, female) Total
26 73
37 153
F)a 16 (2E,F)a 48 (6E,F)a
79 274
12.5, and E13.5 are shown. Neural tube defects were detected only
es. All exencephalic embryos were female (F).E12.5
epha
(1E,
.5, Elacking both Pax3 and Nf1 (P , 0.05). Of 93 embryos
obtained at E11.5, 5 compound homozygous mutants
s of reproduction in any form reserved.
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83Neural Tube Defects in Nf1/Splotch Mice(Nf12/2, Sp2/2) were obtained. All displayed unusually se-
vere NTDs including both exencephaly and spina bifida. We
also observed NTDs in 4 of 39 compound heterozygous
littermates (3 females and 1 male). One of these had
exencephaly, 1 had spina bifida, and 2 had both exencephaly
and spina bifida. No embryos heterozygous at only the Nf1
locus or the Pax3 locus independently displayed any NTDs
nd no defects were observed among wild-type littermates.
Abnormal Neuroanatomy in Nf1 Mutants
Figure 1 shows examples of exencephalic Nf12/2 embryos
identified at E10.5 (Figs. 1B and 1C). By E13.5 (Figs. 1D and
1E), exencephaly was characterized by tissue overgrowth of
cranial structures in Nf12/2 embryos with cranial NTDs.
Serial sagittal and cross sections were examined to assess
the anatomic and histologic pattern of neural development
and of cranial NTDs (Fig. 2). Nf12/2 mutants displayed
ariable degrees of neuropathology. In embryos with exen-
ephaly, the brain appeared severely malformed (Figs. 1E
nd 2C). Exencephaly in most of the affected embryos
xtended from the rostral forebrain to the hindbrain. How-
ver, in several embryos the most rostral forebrain was
pared. Ventricular chambers were collapsed with thick and
ighly folded neuroepithelium (compare Fig. 2C to 2A).
ome blood vessels were ruptured, causing hemorrhage and
TABLE 2
Neural Tube Defects in Nf1, Splotch Embryos and Early
Lethality of Compound Homozygotes
Nf Sp
E11.5
(No. exencephaly,
spina bifida)
E13.5
(No. exencephaly,
spina bifida) Total
/1 1/1 4 5 9
/1 1/2 10 9 19
/1 2/2 8 (5ES, 3S) 3 (1ES, 2S) 11
/2 1/1 9 8 17
/2 1/2 39 (2ES, 1E, 1S) 25 64
/2 2/2 7 (1ES, 6S) 10 (1ES, 9S) 17
/2 1/1 4 3 7
/2 1/2 7 10 (1E) 17
/2 2/2 5 (5ES) 0a 5
otal 93 73 166
Note. Genotypes of embryos resulting from crosses between
f11/2, Sp1/2 compound heterozygous mice obtained at E11.5 and
13.5 are shown. The numbers of embryos of each genotype with
xencephaly and spina bifida (ES), exencephaly alone (E), or spina
ifida alone (S) are given in parentheses. All compound homozy-
otes had exencephaly and spina bifida, as did some compound
eterozygotes. No embryos that were heterozygous at either locus
lone had neural tube defects. No compound homozygotes were
btained at E13.5, suggesting lethality prior to E13.5.
a x2 5 3.9, P , 0.05, compared to expected Mendelian frequency.dditional tissue damage and distortion, perhaps related to
nown cardiac defects (Lakkis and Epstein, 1998). (We have
Copyright © 1999 by Academic Press. All rightbserved severe cardiac defects in all Nf1-null embryos
xamined at E12.5–13.5.) Some Nf12/2 embryos without
exencephaly had no recognized neuroanatomic abnormali-
ties, whereas others showed histologic defects (Fig. 3). In
these, the lateral ventricles were dilated and the thickness
of the neuroepithelium was uneven. Major anatomic struc-
tures of the nervous system were present in all Nf12/2
mutants with and without exencephaly. However, the
pons, medulla, and rhombic lip sometimes appeared disor-
ganized and the choroid plexus was malformed and defi-
cient in exencephalic and some normocephalic brains (Fig.
3C). In nonexencephalic mouse embryos, the dorsal telen-
cephalic wall, which becomes the cerebral cortex (neocor-
tex), was thinned (Figs. 2B and 3C, “DT”). The basal cranial
mesenchyme in some mutants with and without exen-
cephaly was expanded compared to that of wild-type con-
trols (Fig. 2, “Ms”). The central canal of the spinal cord was
dilated (hydromyelia) in some Nf1-null mutants (Fig. 3D,
“CC”).
The thinned and abnormally formed forebrain of some
Nf1 mutants led us to test for expression of the Pax6 gene,
hich is normally transcribed in the developing forebrain
n a discrete region rostral to the posterior commissure
Stoykova and Gruss, 1994). In the wild-type embryos, Pax6
xpression is detected in prosomere 3 (P3) of the diencepha-
on and the neocortex of the forebrain as well as in the inner
all of the hindbrain (Fig. 4A). In exencephalic Nf12/2
mutants, Pax6 expression was detected in the putative
forebrain region although the neocortex and P3 were poorly
formed (Fig. 4B). This result indicates that Pax6-positive
forebrain precursors are present in the mutants, but fail to
develop into mature structures.
Enlarged Dorsal Root Ganglia in Some Nf1-Mutant
Embryos
Histolologic analysis revealed enlargement of dorsal root
ganglia (DRG) in about 50% of Nf12/2 embryos that we
examined compared to wild-type littermates (Figs. 2D and
2E, arrows; Fig. 5). In some cases, adjacent enlarged ganglia
appeared to fuse (Fig. 2E). We quantitated the difference in
the numbers of cells present in wild-type and in enlarged
mutant DRGs at the forelimb level by staining with
Hoechst 33258 nuclear dye and counting nuclei in 10
adjacent 10-mm transverse sections from each of two wild-
type and two mutant embryos. The boundaries of the DRG
were determined by histology and by performing in situ
hybridization with a neuregulin-specific probe on the same
sections. We found about 2.5 times as many nuclei in
mutant versus wild-type DRGs (9902 vs 3799 nuclei in 20
sections of mutant vs wild type; mean of 495 vs 190 nuclei
per section, respectively). The enlarged DRG of Nf12/2
mutants expressed neuronal markers such as ErbB3 and
neuregulin (Fig. 5) and islet-1 (not shown). neuregulin and
its receptors encoded by the erbB genes play important roles
in regulation of Schwann cell growth and apoptosis (Grin-
span et al., 1996; Rosenbaum et al., 1997). It is possible that
s of reproduction in any form reserved.
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85Neural Tube Defects in Nf1/Splotch Miceneurofibromin modulation of ras pathways downstream of
erbB3 are important for peripheral ganglia growth regula-
tion. neuregulin expression was also more intense and
expanded in the anterior horn of the ventral neural tube
where motor neurons reside (Fig. 5B, “AH”).
Severe Neural Tube Defects in Nf1, Sp-Double
Mutants
In all Nf12/2, Sp2/2 double homozygous embryos that we
dentified, severe defects of neural tube closure that in-
olved both cranial and lumbosacral regions were noted
Fig. 6). Nf12/2 embryos occasionally displayed exencephaly
but never spina bifida. Sp2/2 embryos always had spina
bifida and sometimes also showed exencephaly, though the
cranial NTDs were smaller and neuroanatomic landmarks
were more readily identified than in the compound ho-
mozygotes (Fig. 7). NTDs were never observed in Nf11/2 or
Sp1/2 embryos, whereas we did observe several compound
heterozygous (Nf11/2, Sp1/2) embryos with NTDs (Table 2).
NTDs in double heterozygotes (Nf11/2, Sp1/2) varied in
severity. Spina bifida was sometimes present (Table 2).
Dramatic overgrowth of the basal mesenchymal tissue was
noted when exencephaly was present, as seen in Fig. 7C.
This finding is not present in Sp2/2 (Fig. 7B) or wild-type
Fig. 7A) embryos. In Nf12/2, Sp2/2 compound homozygous
utants examined at E11.5, the brains appeared more
everely malformed than those of Nf12/2 mutants (compare
ig. 7D to 2C). Defective neural tube closure involved all
egions of the brain. The lateral ventricles of the telenceph-
lon were collapsed and the tectum was more extensively
olded than that of Nf12/2 mutants (Fig. 7D). Double ho-
ozygous mutants also had defective dorsal root ganglia
evelopment. These ganglia were small and poorly formed
nd showed disruption in the normal metameric organiza-
ion along the body axis (Fig. 7D).
Nf1 Is Expressed Normally in Splotch Embryos
A Pax3 paired domain binding site had been identified in
the Nf1 gene and this site is capable of mediating transac-
ivation in tissue culture cells when appropriate reporter
onstructs are cotransfected with Pax3 (Epstein et al.,
995). This result, combined with the fact that both Nf1
nd Pax3 are involved in neural crest, cardiac outflow tract,
nd CNS development, led us to determine if Nf1 is
FIG. 1. Neural tube defects in Nf1 mutant embryos. E10.5 (A–C) a
seen in wild-type embryos (A, D). Exencephaly of varying degrees
FIG. 2. Abnormal neuroanatomy and enlarged dorsal root gang
sections of E13.5 wild-type (A, D) and Nf12/2 (B, C, E) embryos are
with (C) exencephaly. Note the thinned dorsal telencephalic wall
exencephaly (C) the neuroepithelium (NE) in the frontal lobes was
root ganglia were enlarged (compare arrows in E to D). CB, cerebellar prim
Ms, mesenchyme.
Copyright © 1999 by Academic Press. All rightregulated by Pax3 in vivo. Nf1 gene expression was exam-
ined in Pax3-deficient Splotch embryos. Radioactive in situ
hybridization analysis using a Nf1-specific antisense ribo-
probe (Lakkis and Epstein, 1998) showed similar domains of
expression in both wild-type and Sp2/2 embryos at E11.5–
3.5 (data not shown). To assay more sensitively for differ-
nces in Nf1 gene expression levels, we performed semi-
uantitative RT-PCR using RNA derived from brains of
ild-type and Sp2/2 E10.5 littermates (Fig. 8). No significant
lterations of Nf1 gene expression in Sp2/2 embryos could
be detected by these methods. Thus, the genetic interaction
between Pax3 and Nf1 that we report does not appear to be
associated with a direct molecular relationship by which
Pax3 regulates transcription of the Nf1 gene.
DISCUSSION
In this study we report structural brain abnormalities in
Nf12/2 mutant embryos, including abnormal development
of the forebrain and exencephaly. NTDs are even more
apparent after breeding Nf1-deficient mice onto a Splotch
background, resulting in more severe developmental neu-
roanatomic defects. These include exencephaly and spina
bifida in some compound heterozygous embryos and severe
neural tube closure defects in all compound homozygotes.
Exencephaly in Nf12/2 mutants is incompletely penetrant
12.5% of homozygous embryos examined) and displays
ariable expressivity. NTDs have not been previously noted
n Nf12/2 embryos, perhaps because previous investigators
ere studying a slightly different allele (Brannan et al.,
994) or because of differences in genetic background.
xencephaly is gender biased in Nf12/2 mice, since it is
significantly more prevalent in females. Interestingly, cra-
nial neural tube defects in humans (as opposed to spina
bifida) are also far more common in females (Burn and
Gibbens, 1979; Chapman et al., 1996), suggesting that
unidentified sex-linked modifiers affect neural tube closure
in Nf1 mice and in humans. Thus, Nf12/2 mice may provide
useful model for the identification of these modifying
enes. Patients with von Recklinghausen neurofibromato-
is harbor one mutant allele of the NF1 gene and suffer from
earning disorders and other cognitive defects that occur to
arying degrees even within families with identical gene
utations. Heterozygous Nf11/2 mice also display learning
eficits (Silva et al., 1997). Cognitive disorders in NF1
13.5 (D, E) embryos are shown. No neural tube abnormalities were
observed in some Nf12/2 embryos (arrows, B, C, E).
Nf1-mutant embryos. Hematoxylin- and eosin-stained sagittal
n. Abnormalities were noted in Nf12/2 embryos without (B, E) and
in the Nf12/2 embryo without exencephaly (B). In embryos with
voluted. In about half of the Nf12/2 embryos examined, the dorsalnd E
was
lia in
show
(DT)
conordium; CP, choroid plexus; HB, hind brain; LV, lateral ventricle;
s of reproduction in any form reserved.
o86 Lakkis et al.FIG. 3. Ventricular dilatation, disorganization, and reduced choroid plexus in Nf1-mutant embryos. Giemsa-stained transverse sections
f E12.5 embryos reveals neuroanatomical defects in nonexencephalic Nf12/2 mice. Transverse sections of wild-type (A, B) and Nf12/2 (C,
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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87Neural Tube Defects in Nf1/Splotch Micepatients are more common in females (Chapman et al.,
1996; Said et al., 1996) and appear to involve predominantly
frontal/subcortical processes (Chapman et al., 1996).
During mouse development, neural tube closure occurs
between E7.5 and E10 and initiates at four separate loca-
tions along the rostral–caudal neural axis (Golden and
Chernoff, 1993). Closure site I is initiated at the spinal
cord–mesencephalon boundary and closure II begins at the
prosencephalic–mesencephalic boundary. Once initiated,
both closures proceed bidirectionally. Closure III starts at
the most anterior point of the neural fold and closure IV is
initiated at the caudal end of the rhombencephalon. These
last two closures proceed unidirectionally until they meet,
thus completing cranial neural tube formation. Defective
neural tube closure in Nf12/2 embryos was centered on the
eveloping diencephalon and extended into the myelen-
ephalon. The most rostral region of the forebrain was
losed. Therefore, the Nf1 mutation predominantly affects
losure II, although other sites are also affected to a lesser
nd more variable extent. Exencephaly was evident by
10.5, the earliest stage examined, at which time the
ephalic neural tube had completely closed in normal
ittermates. This defect remained evident at later stages
E12.5 and E13.5), indicating that the defect was permanent
ather than an example of delayed closure.
The genetic regulation of mammalian neural tube devel-
pment is a highly complex process that is influenced by
any environmental factors and the products of many
enes (Copp et al., 1990; Harris and Juriloff, 1997). These
enes belong to different classes with widely different
iological activities, including transcription factors, proto-
ncogenes, tumor suppressors, signaling molecules, trans-
ort proteins, cytoskeletal proteins, and gap junction pro-
eins (Armstrong et al., 1995; Chen and Behringer, 1995;
chelard et al., 1993; Embury et al., 1979; Epstein et al.,
991; Ewart et al., 1997; Goulding et al., 1991; Homanics et
al., 1995; Labosky et al., 1997; Sah et al., 1995; Schorle et
al., 1996; Shou et al., 1998; Thomas et al., 1991; Xu et al.,
1998; Zhang et al., 1996; Zhao et al., 1994), in addition to
others whose functions have not been identified (Crosby et
al., 1992; Gunther et al., 1994; Harris et al., 1997). Un-
doubtedly, these genetic factors will interact to augment
neural tube developmental defects.
We sought to determine if a genetic interaction exists
between Pax3 and Nf1 because both gene products affect
neural crest derivatives and neural tube closure. In particu-
D) embryos are shown. Infolding and thinning of the dorsal telence
(A). The choroid plexus (CP) was reduced and the ventricles were di
canal (CC) of the neural tube was evident in Nf12/2 embryos (compa
entricle; LV, lateral ventricle.
IG. 4. Pax6 expression indicates presence of frontal lobe prog
ybridization showing Pax6 expression in wild-type (A) and Nf12/2 (
o prosemere 3 (P3) and in the hindbrain (HB). Despite severe CNS malfo
of the presumptive forebrain is evident (B). NC, neocortex.
Copyright © 1999 by Academic Press. All rightlar, both genes have been implicated in neural crest regula-
tion of cardiac outflow tract septation, peripheral ganglia
development, melanocyte function, and Schwann cell de-
velopment. We wanted to determine if Pax3 deficiency and
the resulting neural crest dysfunction would abrogate the
developmental defects seen in Nf1-deficient embryos, spe-
cifically those affecting the developing heart. Instead, our
results suggest a genetic interaction between Nf1 and Pax3
related to neural tube closure and indicate that Nf1 modi-
fies the incidence of exencephaly in a well-established
mouse model of NTDs. The Splotch model is especially
relevant to the study of human neural tube disorders since
it is sensitive to maternal administration of folate (Fleming
and Copp, 1998).
The interpretation of our data is tempered by the differ-
ences in genetic backgrounds of the Splotch (C57Bl/6) and
Nf1 (sv129) mice used. The incidence of many embryonic
phenotypes, including NTDs, in response to genetic or
environmental insults, is known to vary among strains.
Some inbred mouse strains, such as SELH/Bc and NZW,
have an increased genetic predisposition to NTDs (Gunn et
al., 1992; Juriloff et al., 1989; Vogelweid et al., 1993). The
penetrance of NTDs in curly tail mice is estimated to be
24% when crossed with C57Bl/6, but only 0.8% when
crossed to DBA/2 mice (Copp, 1994). Similar data regarding
the incidence of Splotch neural tube defects when crossed
onto different genetic backgrounds is not available. It is
possible that modifiers unrelated to Nf1 would augment the
incidence and severity of Splotch NTDs in embryos result-
ing from a cross with wild-type sv129 mice. No such cross
has been reported, although Splotch mice have been crossed
to myf5-deficient mice that were maintained on a sv129/
C57Bl/6/DBA background (Tajbakhsh et al., 1997). In that
study, NTDs were not reported in Splotch heterozygotes
and the severity of NTDs was not reported to be affected by
the genetic background. A specific genetic interaction be-
tween Nf1 and Splotch in our experiment was suggested by
the high incidence of severe NTDs in compound homozy-
gous embryos. All five of the double-mutant embryos had
severe exencephaly and extensive spina bifida reflecting
large areas of the neural tube that failed to close along the
entire anterior–posterior axis. In addition, extensive infold-
ing and malformations of the cranial neuroepithelium were
present. Fewer than one-third of Splotch homozygotes that
were wild type or heterozygous at the Nf1 locus had
exencephaly (Table 2), and the defects were generally less
c wall (DT) is evident in Nf12/2 sections (C) compared to wild type
(compare C to A). At more caudal regions, dilatation of the central
to B). HB, hindbrain; GE, ganglionic eminence; HT, heart; III, third
rs in exencephalic Nf12/2 mutant embryos. Radioactive in situ
bryos is shown. Pax6 is normally expressed in the forebrain rostralphali
lated
re D
enito
B) emrmations in the Nf12/2 brain shown, Pax6 expression in the region
s of reproduction in any form reserved.
88 Lakkis et al.FIG. 5. Enlarged dorsal root ganglia of Nf12/2 embryos express neuregulin and erbB3. Radioactive in situ hybridization of transverse
sections at the level of the heart of wild-type (A, C) and Nf12/2 (B, D) embryos reveals enlarged dorsal root ganglia (DRG) in mutant mice.
neuregulin expression (A, B) and erbB3 expression (C, D) were detected in DRGs and both were more prominent in mutant sections.
neuregulin expression was also more evident in the anterior horn (AH) of the ventral neural tube, where motor neurons reside, in mutant
(B) than in wild-type (A) embryos.
FIG. 6. Exencephaly and spina bifida in Nf1, Sp compound homozygous embryos. E11.5 wild-type (A) and Nf12/2, Sp2/2 compound mutants
(B, C) are shown. Arrowheads (B, C) indicate the cranial neural tube defects (exencephaly) and arrows indicate lumbosacral neural tube
defects (spina bifida).
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89Neural Tube Defects in Nf1/Splotch Micesevere with preservation of most cranial neuroanatomic
landmarks. In addition, the occurrence of NTDs in com-
pound heterozygous embryos was striking. We have never
observed spina bifida or exencephaly in Splotch heterozy-
otes in our laboratory despite several interstrain crosses
M.L. and J.E., personal observations) and such an observa-
ion has not been reported despite extensive breeding since
he 1950s (Auerbach, 1954). The compound heterozygotes
ith exencephaly were severely affected (Fig. 7D) as were
he compound homozygotes. Finally, the absence of com-
ound homozygotes surviving until E13.5 (while Nf12/2 and
Sp2/2 embryos do survive until this time) strengthens the
rgument for a genetic interaction between Nf1 and Pax3.
The genetic interaction between Nf1 and Pax3, and a
revious observation of a Pax3 binding site in the Nf1 gene
(Epstein et al., 1995), led us to test for a direct regulatory
interaction between these two gene products. However, we
have found no evidence that Pax3 can modify the expres-
sion of the endogenous Nf1 gene in vivo. Nf1 mRNA is
xpressed at comparable levels in the brains of wild-type
FIG. 7. Neuroanatomic defects in Nf, Splotch compound het
eosin-stained sagittal sections of E11.5 wild-type (A), Splotch (B), N
and spina bifida were present in embryos shown in B–D. The dors
shown) compared to wild type (A). The compound heterozygote (C)
FIG. 8. Nf1 expression is unaffected in neural tissue from Splotch
mbryos. Semiquantitative RT-PCR using Nf1-specific primers and
NA extracted from wild-type (lanes 1–4) and Sp2/2 (lanes 5–8)
E10.5 mouse embryo brains. actin primers were used as internal
control in the same RT-PCR. Lanes 1–4 and 5–8 represent decreas-
ing amounts of template added to the PCR. Similar amounts of Nf1
RNA were present in wild-type and Splotch tissue. M, molecular
weight marker VI (Boehringer Mannheim).of the hindbrain (HB) was highly folded in the compound homozygote (D
ventricle.
Copyright © 1999 by Academic Press. All rightnd Splotch embryos as determined by semiquantitative
T-PCR (Fig. 8) and by RNase protection and in situ
ybridization assays (data not shown). Transfection of Pax3
nto C2C12 myoblasts that express Nf1 does not alter
expression levels (data not shown). Although subtle
changes in gene expression below the level of detection of
these techniques remain possible, our data do not support a
direct regulation of Nf1 by Pax3. This result is consistent
with our genetic data, since a direct regulation of Nf1 by
Pax3 would predict that compound homozygous embryos
would phenotypically resemble Splotch embryos. Rather,
we found that inactivation of both genes resulted in a
particularly severe phenotype.
Nevertheless, it is interesting to note that Nf1 and Pax3
are expressed in overlapping domains within the developing
CNS and neural crest-derived structures. Mutations in both
genes affect the development of dorsal root and sympathetic
ganglia. In Splotch embryos these ganglia are diminished or
absent (Auerbach, 1954) while in Nf12/2 embryos the gan-
glia are enlarged (Brannan et al., 1994; Jacks et al., 1994; this
report). Pax3 is expressed in mature Schwann cells (Kioussi
et al., 1995), where its function is unknown, while Nf1 is
required in Schwann cells to maintain proper growth char-
acteristics and responsiveness to neurotrophic factors (Kim
et al., 1995, 1997; Vogel et al., 1995). In compound homozy-
gous embryos, we found small or absent dorsal root ganglia,
indicating that Pax3 is epistatic to Nf1 during dorsal root
ganglia development.
In light of these results, it seems most likely that Pax3
and Nf1 function in parallel pathways that both contribute
to normal neural tube closure. Nf1, by virtue of its ras GAP
activity, may be required for proper modulation of cellular
proliferation during critical periods of neural tube closure.
Pax3 is likely to affect the expression of many downstream
genes, including those encoding extracellular matrix mol-
ecules such as NCAM that may be critical for neural tube
closure (Moase and Trasler, 1991). It is conceivable that
dose-dependent abnormalities in extracellular matrix com-
ponents (related to the Pax3 genotype) and dose-dependent
alterations in ras pathway signaling functions (related to
the Nf1 genotype) could combine to produce augmented
defects in compound mutant embryos.
A small number of genetic interactions affecting neural
tube closure have been previously described, including
those between Splotch and curly tail (Estibeiro et al., 1993),
Nf1 and p120-rasGAP (Henkemeyer et al., 1995), Nf1 and
p53 (Vogel and Parada, 1998), and undulated and Patch
gous and compound homozygous embryos. Hematoxylin- and
, Sp1/2 (C), and Nf12/2, Sp2/2 (D) embryos are shown. Exencephaly
ot ganglia (DRG) were reduced in size in each case (B–D and not
ed overgrowth of mesenchymal tissue (Ms). The neuroepitheliumerozy
f11/2
al ro
show) and the ventricles were collapsed. LV, lateral ventricle; V4, fourth
s of reproduction in any form reserved.
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90 Lakkis et al.(Helwig et al., 1995). Here, we have provided additional
evidence for the role of Nf1 in neural development and we
have demonstrated that Nf1 is a modifier of Pax3-related
NTDs. Further studies are required to understand the
molecular and cellular basis of this genetic interaction and
to further elucidate the complex interactions between ge-
netic and environmental factors that result in neural tube
closure abnormalities.
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